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Obje&e. We sough1 to determine the prevalence and fate of 
residu$ ductal shunting following coil occlusion of patent ductus 
arteriosus. 
&&ground. Althougb transcatheter coil occlusion of patent 
ductus arteriosus has gained popularity, few follow-up data have 
heen reported. 
Methads. A review of 75 patients who underwent coil occlusion 
was performed. Residual shunting was investigated by Doppler 
echocardiography in follow-up. Angiograms were reviewed to 
ebtain minimal ductal diameter and ductal angiographic type 
Results. Residual shunts were found in 31 patients (41%) on the 
day of the procedure, and of these, spontaneous dosure was noted 
in 17 (5%) at 2 weeks to 20 months of follow-up. Of the 75 
patients studied, 5 (7%) required a second coil procedure, and 10 
(13%) remained with persistent residual shunts at most recent 
follow-up. Actuarial analysis estimated a 6 + 5% prevalence of 
residual shunts 20 months after a single coil procedure and 3 + 
Although transcdtheter occlusion of the persistently patent 
ductus arteriosus with Gianturco steel coils has rapidly gained 
popularity (l-6), little data have been reported on the preva- 
lence and fate of residual shunts following coil occlusion. We 
report early to intermediate-term follow-up results in 75 
patients who underwent one or more coil occlusion procedures 
for patent ductus arteriosus at our institution. 
Methods 
Patients. All patients discharged from C.S. Mott Chil- 
dren’s Hospital between October 192 and September 1995 
with one or more Gianturco coils (Cook Inc.) implanted in the 
ductus arteriosus were included in this study. Patient records 
were reviewed to obtain patient age and weight at the time of 
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3% after all coil procedures. Minimal ductal diameter was asso- 
ciated with immediate complete ductal occlusion by a single coil. 
The patients had signiiamtly smaller <p = 0.003) minimal 
ductal diameters (1.2 2 6.7 mm) than thm wi~o required two 
coils during their initial procedure to achieve immediate ocdusion 
(1.9 + 0.7 mm), those I&O required a second coil prwednre (2.0 SC 
0.9 mmj, ihosc who had spontaneous closure of rer.dual shunts 
(1.9 c 0.7 mm) and those with persistent residual shunts (2.0 2 
0.9 mm). No association was identified between ductal am@ 
graphic type and outcome of coil occlusion. No late adverse 
dinical events of coil occlosion or evidence of recanalization was 
found. 
c0nciclrioa.v. Small residual shunts are common after coil 
emboliition of patent ductus arteriosus, but mast close spank+- 
neously. Actuarial analysis estimates complete closure in 94% at 
B munthq aod reintenentioo was required in only 79hfpatients. 
(J Am Co0 Ganiiul19%;28:207-1 I) 
the coil procedure, minimal ducta; diameter by angiography, 
and ductal angiographic type as described by Krichenko ei al. 
(7). Complications of the coil occlusion procedures were also 
noted. along with c,ther significant medical conditions. 
Coil occlusion procedure. Coil occlusion of patent ductus 
arteriosus was performed in a retrograde fashion via the 
femoral artery using the methods of coil selection and implan- 
tation described in our previous report (2). Heparin was 
administered to all patients during catheterization. Certain 
technical aspects of the procedure have evolved with experi- 
ence. Originally, we routinely performed right heart catheter- 
ization. frequently used general endotracheal anesthesia, and 
observed all patients oxmight following coil occlusion. We 
currently perform coil occlusion of the ductus as an outpatient 
procedure using local anesthesia and sedation and perform 
right heart catheterization only when clinically necessary (i.e.. 
for evalsation of coexisting cardiac disease or retrieval of 
coils). Additional coils were implanted during the initial pro- 
cedure at the discretion of the operator, bur only if the 
postimplantation aortic cineangiogram revealed more than a 
trace residual shunt (2). 
Residual shunts. The presence or absence of “immediate” 
(~24 h) residual ductal shunting following coil implantation 
was detkmined by aortic cineangiography, usualIy 10 to 15 min 
after coil implantation and/or by color-flow Doppler echocar- 
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diography before discharge. The ductus was considered fully 
occluded if no residual shunting was seen by color-Row Dopp- 
ler echocardiogram or by aortic cineangiogram if early echo- 
cardiography was not performed. Because we consider echo- 
cardiography more sensitive, if ductal shunting was observed 
on echocardiogram and not on aortic cineangiogram, the 
patient was considered to have a residual shunt. Spontaneous 
closure of residual shunts was considered to have occurred 
when Doppler echocardiography showed no shunt in a patient 
with a previously documented residual shunt. Recatralization 
was considered to have occurred if ductal shunting was de- 
tected in a patient with previous complete occlusion docu- 
mented in follow-up by color-flow Doppler echocardiography. 
This definition was adopted to identify true recanalization of 
the organized thrombus rather than early dynamic changes 
caused by clot retraction and thrombolysis. 
Follow-up. Records of all cardiology outpatient visits at 
C.S. Mott Children’s Hospital, at its outreach clinics and witn 
referring cardiologists were reviewed for the presence of 
residual ductal shunting, ductal recanalization and adverse 
clinical events. The recommended follow-up intervals for these 
patients were 2,6 and 12 months after the coil procedure and 
every year thereafter. Color-flow erbocal:l,ograms were en- 
couraged at most visits; actual follow-up aid testing were 
subject to the preference and circumstances of each patient 
and his or her cardiologist. 
Statistical analysis. The prevalence of residual ductal 
shunts over time was analyzed by the Kaplan-Meier product- 
limit method (LIFETEST, SAS system 6.08, Gary, NC). The 
presence or absence of residual shunting was noted immedi- 
ately following coil occlusion. If residual shunting was noted, 
the time period from coil placement to the first documentation 
of complete ductal occlusion was also noted, if residual shunt- 
ing persisted, the time of most recent follow-up was noted. For 
those who underwent a second coil procedure, the one- 
procedure-only analysis considered those patients “lost to 
fofbw-Up” (i.e., censored) with residual shunts at the time of 
the second procedure. For the all-procedures analysis, results 
of the second coil procedure were entered as if the occlusion 
had been spontaneous; that is, patients with two procedures 
were not entered twice. Actuarial analysis estimates were 
reported with standard errors. The minimal diameter of the 
patent ductus was reported as mean value -+ standard devia- 
tion, and age and weight were expressed as median and range 
because of their skewed distribution. The effect of minimal 
patent ductus arteriosus size on residual shunting was evalu- 
ated by analysis of variance. We selected p < 0.05 to indicate 
statistical significance. 
Results 
Study patients. Coils were successfully implanted into the 
patent ductus arteriosus of 75 patients. A single coil was placed 
in 67 patients; significant residual ,shunting after coil implan- 
tation prompted placement of a second coil, at the initial 
procedure in the remaining 8 patients. A second coil occlusion 
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Table 1. Other Significant Medical Conditiowv Present in 75 
Patients With Patent Ductus Arteriosus 
-- 
No. of 
Diagnosis Patients 
Ahxznt right kidncy 
Aortic stenosis 
Arteriovenour malfornxitions 
Autism 
Bronchopslmonary dpplasia 
Chronic pulmonary disease 
Congenital complete heart hiwk 
Comnq artery disuse 
Doun syndrome 
Hydrocrephalus 
Marfan qndrome 
Mitral regurgitation 
Preview surgical ductal ligation 
Primum atrial srptal drkct (repaired) 
Pulmonary stenosis 
Ventricular wptai defect 
Spntaneouvly closed 
Surgically rcpaircd 
Unrepaired 
1 
1 
I 
I 
1 
1 
I 
I 
4 
1 
1 
3 
3 
I 
3 
6 
? 
I 
3 
procedure was performer in five patients to occlude a persis- 
tent residual shunt. Indications for ductal occlusion included 
clinical signs of congestive heart failure (seven patients), 
amelioration of mitral regurgitation (three patients), broncho- 
pulmonary dysplasia (one patient), angina pectoris with poten- 
tial coronary artery steal (one patient), left ventricular enlarge- 
ment from congenital complete heart block (one patient) and 
reduction of endocarditis risk in 55 patients with continuous 
murmurs and 5 patients with systolic murmurs attributed to 
patent ductus arteriosus. Although we do not generally advo- 
cate treatment of the silent patent ductus arteriosus (8), we 
accepted two such patients for coil occlusion as an alternative 
to planned surgical ligation. At the time of initial coil implan- 
tation, the median age was 3.5 years (range 0.4 to 62), and the 
median weight was 14.6 kg (range 4.6 to 94.5). The mean 
minimal duct diameter was 1.6 5 0.8 mm (range 0.3 to 4.0), 
and ductal angiographic classification included 40 with type A, 
4 with type B, 5 with type C, 8 with type D and 18 with type E 
morphology. A number of other significant medical conditions 
were recorded (Table I). Of particular interest were previous 
surgical ductal ligation in three patient< (one of whom also had 
repair of an atrial septal defect) and one infant with diffuse 
cutaneous, hepatic and pulmonary arteriovenous malforma- 
tions. 
Occlusion results. Complete closure of the patent ductus 
arteriosus (Fig. I) was documented within 24 h of coil occlu- 
sion in 44 patients (58%); 4 of these patients required two coils 
at the initial procedure to achieve complete immediate occlu- 
sion. Thus, 40 of 67 patients achieved immediate closure with 
one coil only, and 4 of 8 patients who received two coils initially 
achieved immediate closure. Spontaneous closure of residual 
shunts was observed in 17 patients (23%) from 2 weeks to 20 
months after coil occlusion. A second coil procedure was 
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Figure 1. Outcome of coil occlusion of patent 
ductus arteriosus in 75 patients. Comnlete uc- 
clusion was confirmed in 87% with immediate 
complete occlusion in 58%, spontaneous cio- 
sure in 23% and complete occlusion after a 
second ceil procedure in 5%. Residual shunts 
are present in 10 patients (13%), includmg 6 
patients early in their follow-up (~12 months) 
and 1 patient with a trace residual shunt after d 
second coil procedure. The three patients with 
persistent residual shunt include one p.tncat 
who is scheduled for a second coil procedure. 
one patient who has refused a second pry- 
dure and one patient with trace residual shuat 
and mitral regurgitation who has no cliurcal 
indication for a second coil procedure. 
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required in five patients (7%) and 11 achieved immediate 
complete occlusion in four. Residudt bhunts persisted at the 
most recent follow-up visit in nine patients with one coil 
procedure (12%). Actuarial analysis (log. 2) estimates a 6 2 
5% prevalence of residual shunts 20 months after a single ceil 
procedure and a 3 t 3% prevalence after all coil procedures. 
The minimal diameter of the p&m ductus significantly 
influenced the prevalence of residual >hunting. The mean 
minimal duct diameter was 2.5 -t 1.1 mm in patients who 
required two ceils for immediate complete occlusion of their 
patent ductus arteriosus at the initial coil procedure, 1.9 t 
0.7 mm in those whose residual shunts closed spontaneously 
Ftture 2. Kaplan-Meier analysis of residual shunting versus months 
after a single coil procedure (sottd line) and alter all coil procedures 
(dotted liw). Actuarial estimates of residual shunt prevalence were 
41 2 6% at 1 day, 15 -C 5% at IO months and 6 it 5% at 20 months 
after a single coil procedure, and 11 ? 95~ at IU months and 3 t 3% 
at 20 months after all coil procedures. lkause residual shunts are 
removed from the analysis at the time of echocardiography (which 
must necessarily follow the true time et rhunt closure), the analysis 
presents a worst-case scenario for the duration of residual shunting. 
during follow-up, 2.0 + 0.9 mm in those who underwent a 
second coil procedure end 2.0 2 0.9 mm in those patients with 
a persistent residual shunt. The minimal duct diameter of these 
groups was significantly (p = 0.303) larger than that of the 
group &t achieved immediate ;umplete closure with one ceil, 
which averaged 1.2 2 0.7 mm. Ductal angiographic type did 
not appear to influence the results of coil occlusion: immediate 
complete closure was achieved in 25 of 40 patients with type A, 
3of4withtypeB,3ofSwithtypeC,7of8withtypeDand 
10 of 18 with type E ductus (chi-square = 2.8, p = 0.60). 
Cmpkdoos and late adverse events. Compfiitions of 
the 80 coil occlusion procedures included three immnces of 
reduced femoral pulse, one instance of femoral pseudoaneu- 
rysm requiring ultrasound-guided compression (in the patient 
with Mar-fan syndrome) and ox case in which a coil beii 
retrieved from the iliac artery became dislodged from the 
retrieval catheter in the inguM subcutaneous tissue and 
required femoral cutdown to complete the retrieval. During 59 
patient-years of follow-up, no instance of late coil migration, 
thromboembolism, endarteritis, hemoiysis, coarctation or sig- 
nificant acquired left puhnonary artery stenosis was noted. 
Recanalization of successfu$ coil-occhrded patent ductus 
arteriesus was not observed (see Disc&in). There was one 
death in the infant with multiple arteriovenous malformations, 
which was secondary to progressive, intractable congestive 
heart failure 2 months after successful coil occlusion of the 
patent ductus. 
The present study reports our experience with ah 75 
patients who underwent coil implantation in the patent ductus 
arteriosus at our institution betwecrr October 1992 and Sep 
tember 1995. It is based on a total accumulated 59 patient- 
years of experience. The early prevalence of residual shunt 
(41%) was high compared to other pubhshed trials. Hijazi and 
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Geggel (6) reported residual shunting in only 3% of 31 
patients, most of whom received multiple coils. The higher rate 
of residual shunts in our series may reflect our early approach 
of avoiding implanting a second coil immediately unless the 
residual shunt was thought significant. Importantly, our follow-up 
data demonstrate that most small residual shunts will close 
spontaneously. Spontaneous closure ocCurre? in 55% (17 of 
31) of patients with a residual ductal shunt o\cr 2 weeks to 20 
months of follow-up. Actuarial estimates of residual shunt 
prevalence were 41% 6% at 1 day, 15 t 5% at 10 months, and 
6 ? 5% at 20 months after coil placement (Fig. 2). These data 
compare favorably to the report of Hosking et al. (9), who 
reported prevalences of residual shunt after ductal occlusion 
with the Rashkind device of 53% at 1 day, 38% at 1 year and 
18% at 2 years. 
Persistent residual shunts. Residual shunts have persisted 
in 14 of our patients, 5 of whom have undergone second coil 
procedures with immediate complete occlusion in 4 patients. A 
second coil occlusion procedure has been recommended to 
one patient whose residual shunt has persisted for > 19 months 
but who has refused further intervention, and one patient is 
scheduled for second coil procedure. Six patients who are early 
in their follow-up are being observed in anticipation of spon- 
taneous closure. The remaining patient, who has a clinically 
silent residual shunt at 14 months of follow-up, is prescribed 
endocarditis prophylaxis for mitral regurgitation, and indica- 
tions for further intervention are unclear. 
Gnnpliitions. Potential complications of coil occlusion 
include recanalization, endarteritis and acquired coarctation of 
the aorta or left pulmonary artery stenosis. During 59 patient- 
years of follow-up, none of these complications has been 
encountered. Events possibly indicating recanalization but not 
meeting our definition were observed in two patients. Both 
patients had complete ductal occlusion confirmed by Doppler 
echocardiography performed during their coil occlusion pro- 
cedures (one was a repeat coil occlusion procedure for persis- 
tent residual shunt). Residual shunts were identified on their 
initial (2 and 14 months) follow-up echocardiograms. Data are 
insufficient to determine whether these residual shunts devel- 
oped early, from minor changes: in coil position and thrombus 
size from clot retraction and thrombolysis, or developed late, 
from true recanalization. Although recanalization of aortopul- 
monary collaterals after coil embolization has been described 
(lo), we consider it more likely that our patients’ residual 
shunts developed during the early dynamic phase of thrombus 
maturation. 
Evidence for acquired left pulmonary artery stenosis has 
been sought aggressively and systematically (ll), and no 
clinically significant changes in left pulmonary artery size or 
fiow velocity were found. The highest left pulmonary artery 
Doppler fiow velocity noted in follow-up was ?.I m/5. With the 
maio. pulmonary artery flow velocity of 0.9 m/s taken into 
munt, a peak instantaneous pressure gradient of 14 mm Hg 
would be predicted in this patient. Pullback pressures recorded 
at the time of the ooil procedure demonstrated a peak-to-peak 
‘iptdii gradient of 5 mm Hg between the main and left 
pulmonary artery both before and after coil placement. We 
speculate that minimizing the number of coils implanted may 
have reduced the risk of left pulmonary artery stenosis re- 
ported with use of multiple coils (6) or the larger Rashkind 
device (12). 
Predictors of occlusion. We examined duct size and angio- 
graphic type in an attempt to predict which patients might be 
at increased risk for persistent residual shunting. Although 
patients with immediate complete occlusion had significantly 
smaller minimal duct diameters on average, duct size did not 
distinguish between patients with persistent shunts and those 
whose shunts closed spontaneously during follow-up. No sig- 
nificant association between ductal angiographic type and 
outcome was observed. Actuarial analysis of those who were 
discharged with one coil and trace residual shunts reveals that 
the majority will close spontaneously. In the eight patients who 
had two coils implanted at their initial procedure, four 
achieved immediate closure, two patients had spontaneous 
closure of their residual shunt, and two await spontaneous 
closure or repeat intervention. These results, which are similar 
to the study group as a whole, imply that our criteria for initial 
placement of a second coil were reasonable. However, the 
statistical power of this comparison is limited, and further 
experience may help to identify patients in whom residual 
shunts should be treated more aggressively at the initial 
procedure. 
Implications. Our findings suggest that most residual 
shunts will resolve spontaneously. We therefore advocate 
minimizing the number of coils implanted by placing a second 
coil only if the postcoil aortogram shows a residual shunt of 
more than trace severity (2). Results of early (within the first 
24 h after coil occlusion) echocardiography have not altered 
clinical decisions, so we do not obtain routine echocardiograms 
until the first follow-up visit. We recommend an initial follow-up 
visit at 6 months for patients with immediate duct closure, at 
which time endocarditis precautions can be discontinued if 
complete closure is confirmed. We continue to examine pa- 
tients with known residual shunts at 2 months. We advocate 
early second coil procedures for patients with significant 
residual shunt (i.e., those with ductal murmurs or increasing 
magnitude of shunt by echocardiogram). For trace residual 
shunts, we recommend a second coil procedure only if the 
shunt persists for 12 months or more. This strateg should 
achieve a complete closure rate approaching 100%. 
ConcMot~s. Follow-up of 75 patients indicates that coil 
occlusion is a safe and effective treatment for patent ductus 
artegosus. Recanalization and late adverse clinical effects of 
coil occlusion have not occurred in 59 patient years of follow- 
up. One patient death occurred in our series and was umelated 
to the patent ductus arteriosus or the coil procedure. Actuarial 
analysts predicts 94% complete ductal closure 20 months after 
a single coil occlusion procedure. Residual shunts are com- 
monly observed immediately following coil occlusion proce- 
dures, but spontaneous closure occurs in the majority. Patients 
with smaller minimal duct diameters are more likely to achieve 
immediate occlusion following placement of a single coil, but 
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July IWh:207-I I 
duct size dccs not predict those who wi!! have spmtaneous 
resolution of their residual shunts. Based on these data, we 
consider percutaneous coil occlusion to be the treatment of 
choice of children with a restrictive patent ductus arteriosus. 
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